Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Baldwin

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar CancerMaaike H M Oonk, François Planchamp, Peter Baldwin, et al.
World Journal of Urology|October 2, 2021
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissectionsPaul Lloyd, Anne Hong, Marc A Furrer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 27, 2023
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023Maaike H M Oonk, François Planchamp, Peter Baldwin, et al.
Scientific Reports|July 26, 2019
Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancerSurrin S Deen, Andrew N Priest, Mary A McLean, et al.
BJR Open|September 15, 2022
Magnetization transfer imaging of ovarian cancer: initial experiences of correlation with tissue cellularity and changes following neoadjuvant chemotherapySurrin S Deen, Mary A McLean, Andrew B Gill, et al.
European Journal of Radiology Open|April 30, 2019
Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancerSurrin S Deen, Frank Riemer, Mary A McLean, et al.
Nature Communications|October 26, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancerFilipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar CancerMaaike H M Oonk, François Planchamp, Peter Baldwin, et al.
World Journal of Urology|October 2, 2021
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissectionsPaul Lloyd, Anne Hong, Marc A Furrer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 27, 2023
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023Maaike H M Oonk, François Planchamp, Peter Baldwin, et al.
Scientific Reports|July 26, 2019
Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancerSurrin S Deen, Andrew N Priest, Mary A McLean, et al.
BJR Open|September 15, 2022
Magnetization transfer imaging of ovarian cancer: initial experiences of correlation with tissue cellularity and changes following neoadjuvant chemotherapySurrin S Deen, Mary A McLean, Andrew B Gill, et al.
European Journal of Radiology Open|April 30, 2019
Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancerSurrin S Deen, Frank Riemer, Mary A McLean, et al.
Nature Communications|October 26, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancerFilipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago, et al.
Pageof 5